[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gastrointestinal Tract Cancer Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 126 pages | ID: G5C61A79049EN
VPAResearch

US$ 630.00 US$ 700.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Gastrointestinal Tract Cancer ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Gastrointestinal Tract Cancer disease clinical trials. The research work analyzes the ongoing Gastrointestinal Tract Cancer clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Gastrointestinal Tract Cancer treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Gastrointestinal Tract Cancer clinical trials.

Scope of the Report-
  • Ongoing Gastrointestinal Tract Cancer clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Gastrointestinal Tract Cancer
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Gastrointestinal Tract Cancer clinical trials
Reasons to Buy
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Gastrointestinal Tract Cancer Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Gastrointestinal Tract Cancer Trials by Phase
3.2 Ongoing Gastrointestinal Tract Cancer Trials by Type
3.3 Ongoing Gastrointestinal Tract Cancer Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Gastrointestinal Tract Cancer Trials
4.2 Top 10 Countries conducting Gastrointestinal Tract Cancer Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Gastrointestinal Tract Cancer Trials by Sponsor Type
5.2 Gastrointestinal Tract Cancer Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Gastrointestinal Tract Cancer Trials by year
6.2 Subjects Recruited for Gastrointestinal Tract Cancer Trials by Phase
6.3 Subjects Recruited for Gastrointestinal Tract Cancer Trials by Trial Type
6.4 Subjects Recruited for Gastrointestinal Tract Cancer Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Gastrointestinal Tract Cancer Trials- Phase
7.2 Ongoing Gastrointestinal Tract Cancer Trials- Phase
7.3 Ongoing Gastrointestinal Tract Cancer Trials- Phase
7.4 Ongoing Gastrointestinal Tract Cancer Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

LIST OF FIGURES

Figure 1: Gastrointestinal Tract Cancer- Clinical Trials by Country
Figure 2: Gastrointestinal Tract Cancer- Clinical Trials by Phase of Development, 2018
Figure 3: Gastrointestinal Tract Cancer- Clinical Trials by Status, 2018
Figure 4: Gastrointestinal Tract Cancer- Clinical Trials by Type, 2018
Figure 5: Gastrointestinal Tract Cancer- Clinical Trials Split by Region, 2000-2018
Figure 6: Gastrointestinal Tract Cancer- Clinical Trials by Type of Economy, 2018
Figure 7: Gastrointestinal Tract Cancer- Enrolment by Phase, 2018
Figure 8: Gastrointestinal Tract Cancer- Enrolment by Trial Type, 2018
Figure 9: Gastrointestinal Tract Cancer- Enrolment by Recruitment Status, 2018
Figure 10: Gastrointestinal Tract Cancer- Clinical Trials by Sponsor Type, 2018
Figure 11: Gastrointestinal Tract Cancer- Enrolment by Type of Sponsors
Figure 12: Gastrointestinal Tract Cancer- Enrolment by Leading Sponsors

LIST OF TABLES

Table 1: Gastrointestinal Tract Cancer- Clinical Trials by Sponsor Type, 2018
Table 2: Gastrointestinal Tract Cancer- Clinical Trials by Economy Type, 2018
Table 3: Gastrointestinal Tract Cancer- Clinical Trials by Region, 2018
Table 4: Gastrointestinal Tract Cancer- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Gastrointestinal Tract Cancer- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Gastrointestinal Tract Cancer- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Gastrointestinal Tract Cancer- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Gastrointestinal Tract Cancer- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Gastrointestinal Tract Cancer- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company


More Publications